Latest: The promise of proteomics: Transforming healthcare from treatment to disease prevention
Latest: Free masterclass on oligo printing via enzymatic DNA synthesis
Latest: LevitasBio announces new approaches to sample preparation and cell enrichment
Latest: MOBILion Systems rolls out red carpet for MOBIE at hometown American Society for Mass...
Latest: ‘Challenges are easier to overcome if you collaborate’
Latest: Volumetric titration: A step-by-step guide to correct results
Latest: HPLC: 5 top resources to maximize accurate data generation
The promise of proteomics: Transforming healthcare from treatment to disease prevention
Virtual Biopharma Summit 2021: Poster highlights
Accelerated renewables-based electrification paves the way for a post-fossil future
Scorpii advanced illumination system for microspectroscopy
Free masterclass on oligo printing via enzymatic DNA synthesis
Optimizing cryopreserved tissue samples using cell sorting to study cellular heterogeneity
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Labguide - Sample preparation strategies
A unified solid phase extraction platform for disk and cartridge based extractions
DNAscope: A novel chromogenic in-situ hybridization technology for high-resolution detection of...
Probumin bovine serum albumin (BSA)
Biophysical Characterization Technology
How to buy next-generation sequencing
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
14 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
04 Apr 22 - 08 Apr 22
09 May 22 - 13 May 22
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have provided an update on the MOVe-OUT study of molnupiravir (MK-4482, EIDD-2801), an investi...Read Full ArticleDiane Li